2022
DOI: 10.3389/fonc.2022.908907
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangiocarcinoma

Abstract: ObjectiveThis study evaluated the prognostic significance of preoperative neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR) and tumor-infiltrating lymphocytes (TILs), and whether these preoperative blood inflammatory indicators were associated with TILs in hilar cholangiocarcinoma (HCCA).MethodsA total of 76 patients with HCCA who underwent radical resection were included. Data on their clinicopathologic characteristics, perioperative features, and sur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 30 publications
1
12
0
Order By: Relevance
“…Fan’s study showed that a higher FLR was significantly related to poor OS and DFS for ESCC ( 38 ). In ECC, Ji’s study showed that an increased NLR was related to poor prognosis for patients with DCC ( 39 ), and Lin’s study showed that a high LMR could predict poor prognosis in patients with PCC after R0 radical resection ( 11 ). However, these were not studies comparing the prognostic power of inflammatory indicators for ECC.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Fan’s study showed that a higher FLR was significantly related to poor OS and DFS for ESCC ( 38 ). In ECC, Ji’s study showed that an increased NLR was related to poor prognosis for patients with DCC ( 39 ), and Lin’s study showed that a high LMR could predict poor prognosis in patients with PCC after R0 radical resection ( 11 ). However, these were not studies comparing the prognostic power of inflammatory indicators for ECC.…”
Section: Discussionmentioning
confidence: 99%
“…High NLR, platelet-to-lymphocyte ratio (PLR), and FAR values and low lymphocyte-to-monocyte ratio (LMR) values could be prognostic factors for short overall survival (OS) in patients with CCA ( 10 12 ). There have been some studies on ICC ( 13 16 ); however, very few studies have referred to ECC, PCC ( 11 ), and DCC ( 17 , 18 ). Additionally, no study has yet explored whether inflammatory indicators such as fibrinogen, neutrophil, fibrinogen-to-lymphocyte ratio (FLR), and FPR could be prognostic markers for patients with ECC.…”
Section: Introductionmentioning
confidence: 99%
“…[7] Many inflammatory mediator-based neogenetic markers, such as neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR), can be used to evaluate the prognosis of cancer patients and have attracted widespread interest because they are intuitive, readily available, and inexpensive markers. [8,9] Recently it has been shown that preoperative white blood cells to hemoglobin ratio (WHR) are related to poor prognosis in patients with hepatocellular carcinoma after hepatectomy. [10] Meanwhile, preoperative fibrinogen to albumin ratio (FAR) has been shown to be associated with poor prognosis in a variety of cancers.…”
Section: The Authors Have No Conflicts Of Interest To Disclosementioning
confidence: 99%
“…These serum indicators are often economical and readily available as part of normal preoperative testing. Currently, studies have confirmed the predictive role of circulating inflammatory markers and their ratios in solid tumors, including lung cancer ( 20 ), penile cancer ( 21 ), cervical cancer ( 22 ), colorectal cancer ( 23 ), thyroid carcinoma ( 24 ), bladder cancer ( 25 ), esophageal squamous cell carcinoma ( 26 ), Hilar Cholangiocarcinoma ( 27 ), breast cancer ( 28 ), et al. Compared to peripheral solid tumors, only a limited number of studies have reported the diagnostic value of circulating inflammatory markers in gliomas ( 3 , 29 , 30 ).…”
Section: Introductionmentioning
confidence: 97%
“…These serum indicators are often economical and readily available as part of normal preoperative testing. Currently, studies have confirmed the predictive role of circulating inflammatory markers and their ratios in solid tumors, including lung cancer (20), penile cancer (21), cervical cancer (22), colorectal cancer (23), thyroid carcinoma (24), bladder cancer (25), esophageal squamous cell carcinoma (26), Hilar Cholangiocarcinoma (27), breast cancer (28), et al Compared to peripheral solid tumors, only a limited number of studies have reported the diagnostic value of circulating inflammatory markers in gliomas (3,29,30). Moreover, most relevant studies have focused on survival and recurrence in GBM patients, and there are no in-depth studies on inflammatory markers and their ratios in the diagnosis, grading and molecular typing of glioma, and the reported studies have not reached uniform conclusions.…”
Section: Introductionmentioning
confidence: 97%